Asymmetric dimethylarginine (ADMA) plays a crucial role in endothelial function and maybe a link for the known interaction of periodontitis and coronary heart disease (CHD). In this pilot study, we compared the impact of gingival health, periodontitis (CP), CHD or of both diseases (CP+CHD) on salivary and serum ADMA levels.

Evaluation of salivary and serum asymmetric dimethylarginine (ADMA) levels in patients with periodontal and cardiovascular disease as subclinical marker of cardiovascular risk

Isola, Gaetano
Primo
Writing – Review & Editing
;
Ientile, Riccardo
Penultimo
;
2020

Abstract

Asymmetric dimethylarginine (ADMA) plays a crucial role in endothelial function and maybe a link for the known interaction of periodontitis and coronary heart disease (CHD). In this pilot study, we compared the impact of gingival health, periodontitis (CP), CHD or of both diseases (CP+CHD) on salivary and serum ADMA levels.
ADMA; C-reactive protein; cardiovascular disease; clinical trial; coronary heart disease; endothelium; periodontitis
File in questo prodotto:
File Dimensione Formato  
Isola et al 2020 JOP.pdf

solo utenti autorizzati

Tipologia: Versione Editoriale (PDF)
Dimensione 518.12 kB
Formato Adobe PDF
518.12 kB Adobe PDF   Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/375154
Citazioni
  • ???jsp.display-item.citation.pmc??? 61
  • Scopus 76
  • ???jsp.display-item.citation.isi??? 91
social impact